Business Wire
,FOXO Technologies™ collaborates with DataRobot to pave the way for AI-driven epigenetic biomarker research in human longevity
FOXO Technologies™ collaborates with DataRobot to pave the way for AI-driven epigenetic biomarker research in human longevity
FOXO Technologies announced second quarter 2023 financial results
Longevity biotech companies GERO and FOXO Technologies™ to embark on joint initiative on artificial intelligence and epigenetic data to discover signatures of human health trajectories
FOXO Technologies launches bioinformatics services to revolutionize epigenetic data analysis
FOXO Technologies announces first quarter 2023 financial results
FOXO Technologies announces direct-to-consumer launch of Longevity Report (beta) product
Recent transactions and the expansion of our management team have made this website outdated. We are currently updating the site and look forward to having a new site available to you shortly. Until we do, please review our SEC filings and press releases here.